Assura Plc (LON:AGR – Get Free Report) reached a new 52-week low during mid-day trading on Tuesday . The company traded as low as GBX 35.60 ($0.44) and last traded at GBX 35.60 ($0.44), with a volume of 14356275 shares. The stock had previously closed at GBX 36.14 ($0.44).
Assura Price Performance
The company has a 50-day moving average of GBX 38.42 and a 200-day moving average of GBX 40.35. The company has a debt-to-equity ratio of 85.04, a quick ratio of 2.84 and a current ratio of 0.89. The stock has a market cap of £1.19 billion, a price-to-earnings ratio of -3,648.00, a PEG ratio of 3.60 and a beta of 0.37.
Assura Announces Dividend
The business also recently declared a dividend, which was paid on Wednesday, January 15th. Stockholders of record on Thursday, December 12th were paid a dividend of GBX 0.84 ($0.01) per share. This represents a dividend yield of 2.12%. The ex-dividend date of this dividend was Thursday, December 12th. Assura’s dividend payout ratio (DPR) is presently -30,000.00%.
Assura Company Profile
Assura plc is a specialist healthcare property investor and developer. We enable better health outcomes through our portfolio of more than 600 healthcare buildings across the UK and Ireland, from which over six million patients are served.
We BUILD for health, having developed over 100 new healthcare buildings in our history, and at the heart of our strategy sits The Bigger Picture; Healthy Environment (E), Healthy Communities (S), Healthy Business (G).
Assura plc achieved B Corp certification in July 2024 – the first FTSE 250 business to do so.
Featured Stories
- Five stocks we like better than Assura
- What is the S&P/TSX Index?
- 3 Cheap Small-Cap Banks for Dividend Growth Investors
- Airline Stocks – Top Airline Stocks to Buy Now
- 3 Defensive Stocks Analysts Are Bullish on to Kick Off the Year
- What is Forex and How Does it Work?
- Vistra Corp: Could 2025 Continue Its Streak of Outperformance?
Receive News & Ratings for Assura Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Assura and related companies with MarketBeat.com's FREE daily email newsletter.